Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?

Author： Cocco Giuseppe  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.13, Iss.17, 2012-12, pp. : 2429-2432

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiac Metabolism in Myocardial Ischemia

By  

Current Pharmaceutical Design, Vol. 14, Iss. 25, 2008-09 ,pp. : 2551-2562

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Adult Progenitor Cells in the Management of Chronic Myocardial Ischemia

By Raval Amish N.  

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 5, 2008-01 ,pp. : 315-326

Adis International

Access to resources Recommend Favorite

Hyperoxemic Perfusion for Treatment of Reperfusion Microvascular Ischemia in Patients with Myocardial Infarction

By Bartorelli A.L.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 4, 2003-01 ,pp. : 253-263

Adis International

Access to resources Recommend Favorite

Effect of &bgr;-Blockers on Perioperative Myocardial Ischemia in Patients Undergoing Noncardiac Surgery

By  

Current Drug Targets, Vol. 10, Iss. 9, 2009-09 ,pp. : 833-841

Bentham Science Publishers

Access to resources Recommend Favorite

Endoxin Antagonist Lessens Myocardial Ischemia Reperfusion Injury

By Ke Yong-Sheng   Wang De-Guo   Wang   He-Gui   Yang Shang-Yin  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 4, 2004-07 ,pp. : 289-293

Springer Publishing Company

Access to resources Recommend Favorite